Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 4016-4023, November 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Epstein, P. M.
Right arrow Articles by Thompson, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Epstein, P. M.
Right arrow Articles by Thompson, W. J.

Increased Cyclic Nucleotide Phosphodiesterase Activity Associated with Proliferation and Cancer in Human and Murine Lymphoid Cells1

P. M. Epstein2, J. S. Mills, C. P. Ross, S. J. Strada, E. M. Hersh and W. J. Thompson

Department of Pharmacology, The University of Texas Medical School at Houston and The University of Texas Systems Cancer Center, M. D. Anderson Hospital, Houston, Texas 77030

Guanosine cyclic 3':5'-monophosphate phosphodiesterase activity of murine leukemic cells (L1210) was 400 times that of human peripheral blood lymphocytes and 15 times that of murine splenic lymphocytes. Adenosine cyclic 3':5'-monophosphate (cyclic AMP) phosphodiesterase activity of L1210 cells was 320 times that of human peripheral blood lymphocytes and 24 times that of normal murine lymphocytes. The total cyclic AMP and guanosine cyclic 3':5'-monophosphate phosphodiesterase activities of rapidly growing cultured human lymphoid cells (normal and leukemic lymphoblastoid cell lines) were also markedly elevated when compared to quiescent peripheral blood lymphocytes. Human peripheral blood lymphocytes stimulated by phytohemagglutinin showed a 10-fold increase in total enzyme activity.

Leukemic and normal murine cells contain a low-affinity cyclic AMP phosphodiesterase as normally observed in most mammalian tissues. In contrast, kinetic analyses of cyclic AMP phosphodiesterase activities of human B and T lymphoblastoid cells were similar to those of peripheral blood lymphocytes in that no evidence of a low-affinity enzyme was found. All the lymphoid cells tested showed a 3 to 4 S enzyme form by linear sucrose gradient fractionation. Proliferating and quiescent human cells also contain a higher-molecular-weight cyclic AMP-specific form (5.9 S), while the murine cells contain a 7.0 S higher-molecular-weight form. Both the 5.9 and 7.0 S forms show anomalous kinetic behavior. These results are discussed with respect to the biochemical nature of cyclic nucleotide phosphodiesterases and the role of this enzyme system in the proliferation of lymphoid cells.

1 Supported by USPHS Grants GM-21361, CA-05831, CA-14984, and CA-14980-03 and the Pulaski County Cancer Society.

2 Fellow of The Rosalie B. Hite Foundation.

Received 3/10/77. Accepted 7/29/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.